Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Angela Bryan to Dronabinol

This is a "connection" page, showing publications Angela Bryan has written about Dronabinol.

 
Connection Strength
 
 
 
2.345
 
  1. Bidwell LC, Martin-Willett R, Skrzynski C, Lisano J, Ortiz Torres M, Giordano G, Hutchison KE, Bryan AD. Acute and Extended Anxiolytic Effects of Cannabidiol in Cannabis Flower: A Quasi-Experimental ad libitum Use Study. Cannabis Cannabinoid Res. 2024 Aug; 9(4):1015-1027.
    View in: PubMed
    Score: 0.737
  2. Gibson LP, Giordano GR, Bidwell LC, Hutchison KE, Bryan AD. Acute Effects of Ad Libitum Use of Commercially Available Cannabis Products on the Subjective Experience of Aerobic Exercise: A Crossover Study. Sports Med. 2024 Apr; 54(4):1051-1066.
    View in: PubMed
    Score: 0.733
  3. Bidwell LC, Martin-Willett R, Melendez SN, Rosa L, Giordano G, Hutchison KE, Bryan AD. LOTUS: Protocol for a double-blind placebo controlled randomized trial of hemp-derived cannabidiol for the treatment of cannabis use disorder. PLoS One. 2024; 19(9):e0308262.
    View in: PubMed
    Score: 0.193
  4. Chen MY, Kramer EB, Gibson LP, Bidwell LC, Hutchison KE, Bryan AD. Investigating the Relationship Between Cannabis Expectancies and Anxiety, Depression, and Pain Responses After Acute Flower and Edible Cannabis Use. Cannabis Cannabinoid Res. 2025 Feb; 10(1):71-80.
    View in: PubMed
    Score: 0.187
  5. Gibson LP, Karoly HC, Ellingson JM, Klawitter J, Sempio C, Squeri JE, Bryan AD, Bidwell LC, Hutchison KE. Effects of cannabidiol in cannabis flower: Implications for harm reduction. Addict Biol. 2022 01; 27(1):e13092.
    View in: PubMed
    Score: 0.156
  6. Bidwell LC, Ellingson JM, Karoly HC, YorkWilliams SL, Hitchcock LN, Tracy BL, Klawitter J, Sempio C, Bryan AD, Hutchison KE. Association of Naturalistic Administration of Cannabis Flower and Concentrates With Intoxication and Impairment. JAMA Psychiatry. 2020 08 01; 77(8):787-796.
    View in: PubMed
    Score: 0.145
  7. Skrzynski CJ, Napolitan A, Hitchcock L, Minhas M, MacKillop J, Bryan AD, Bidwell LC. Cannabis Involvement and Demand in Frequent Concentrate Users Versus Predominantly Flower Users. J Stud Alcohol Drugs. 2023 03; 84(2):214-221.
    View in: PubMed
    Score: 0.042
  8. Bidwell LC, Karoly HC, Torres MO, Master A, Bryan AD, Hutchison KE. A naturalistic study of orally administered vs. inhaled legal market cannabis: cannabinoids exposure, intoxication, and impairment. Psychopharmacology (Berl). 2022 Feb; 239(2):385-397.
    View in: PubMed
    Score: 0.039
  9. Steeger CM, Hitchcock LN, Bryan AD, Hutchison KE, Hill KG, Bidwell LC. Associations between self-reported cannabis use frequency, potency, and cannabis/health metrics. Int J Drug Policy. 2021 11; 97:103278.
    View in: PubMed
    Score: 0.038
  10. Gibson LP, Gust CJ, Ellingson JM, YorkWilliams SL, Sempio C, Klawitter J, Bryan AD, Hutchison KE, Cinnamon Bidwell L. Investigating sex differences in acute intoxication and verbal memory errors after ad libitum cannabis concentrate use. Drug Alcohol Depend. 2021 06 01; 223:108718.
    View in: PubMed
    Score: 0.038
  11. Winiger EA, Hitchcock LN, Bryan AD, Cinnamon Bidwell L. Cannabis use and sleep: Expectations, outcomes, and the role of age. Addict Behav. 2021 01; 112:106642.
    View in: PubMed
    Score: 0.036
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)